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AB0305 FACTORS CONSIDERED BY RHEUMATOLOGISTS TO DECIDE TREATMENT DURING RHEUMATOID ARTHRITIS PATIENT'S FOLLOW-UP
Background: Disease activity (DA) is the most important factor in the treatment decision during rheumatoid arthritis (RA) patient's follow-up. In routine clinical practice, it is recommended to regularly evaluate DA and musculoskeletal ultrasound has been suggested to add value to establish the level of DA. Nevertheless, the final treatment proposal also requires considering additional factors. In a previous clinical study performed in the setting of an early arthritis clinic, we found that in 20% of the clinical scenarios evaluated, the German ultrasound score of 7 joints (GUS-7) (1) findings impacted the rheumatologist 's treatment proposal; the impact was more frequent among the trainee in rheumatology (TR) than among the senior rheumatologist (SR). Objectives: To determine and rate, which among the following factors were determinant to recommend a treatment in the same population of RA patients above described: the clinical assessment, the GUS-7, comorbidities, treatmentrelated adverse events, DMARDs costs/availability, patient's preference and DMARD maximum dose. We also compared if factors differed between both physicians. Methods: Eighty-seven consecutive and randomly selected RA outpatients were invited to participate; 2 patients denied and 85 patients underwent 170 assessments (85 each by the SR and the TR); at first, both physicians (blinded to each other) performed a clinical evaluation that included DAS28 scoring and recommended a RA-treatment. Then, patients underwent GUS-7 by a blinded (to clinical evaluations) rheumatologist. In the final step, the TR and the SR integrated the US findings to their previous evaluation and reviewed their prescription; also, both physicians recorded and rated on a standardized format which of the factors above described were determinant in the final treatment proposal. Patients signed informed consent and were instructed about the process. Only the SR met each patient for the final recommendation. Descriptive statistics was used. Results: Patients were primarily middle-aged female (91.4%) and had (mean±SD) follow-up of 7.5±3.9 years. The majority of them were in DAS28-remission (72%). Clinical assessment (DAS28) was rated as determinant in the totality of the clinical scenarios (100%), followed by GUS-7 in 84.7%, DMARD maximum dose in 41.2%, comorbidities in 23.5%, DMARD cost/availability in 21.2%, treatmentrelated adverse events in 20% and patient's preference in 14.1% of them. The SR and the TR differed in their selection: GUS-7 and treatment-related adverse events were more frequently considered determinant for the TR (45.9% vs. 38.8%, p=0.01 and 12.9% vs. 7.1%, p=0.08), meanwhile the opposite figure was true for DMARD cost/availability (4.7% vs. 16.5%, p≤0.001) and DMARDs maximum doses (17.1% vs. 24.1%, p=0.08). Conclusions: in a real clinical setting, DA assessed by DAS28 and by musculoskeletal ultrasound were the most important factors to determine the treatment of RA outpatients; additional factors were considered and differently rated by TR and SR. Background: Caplan's syndrome was first described in the coal miners of South Wales (UK). The specific cause for rheumatoid pulmonary nodules associated with coal dust exposure remains unknown. Coal dust exposure alone does not appear to explain Caplan's syndrome as almost all of these men were also smokers. Cigarette smoke is the most important environmental cause of cadmium exposure. We describe Caplan's syndrome in an ex-smoking kaolin worker associated with a significantly raised urinary cadmium level. Objectives: A 65 year old Cornish kaolin worker and ex-smoker of 20 pack years with life limiting nodular erosive rheumatoid arthritis (RA), developed extra-articular manifestations including pulmonary nodules suggestive of Caplan's syndrome. We review the literature on kaolin, with respect to inhalation and mechanism of action for heavy metal adsorption and nodular disease development. Methods: Pubmed searches were undertaken using the keywords "kaolinosis", "kaolin", "cadmium" "nodules", "adsorption", "coal". First pass mid-stream urine was analysed for cadmium using inductively coupled plasma-mass spectrometry (ICP-MS).
1 Results: Urinary cadmium was significantly raised at 0.66 μmol/mol creatinine (non-occupationally exposed UK male median 0.17μmol/mol creatinine 1 ), 20 years post-industrial exposure and 35 years post-smoking cessation. Contemporary serology levels demonstrated a rheumatoid factor of 481.7 iu/ml (0-10 normal range) and an anti-cyclic citrullinated peptide of >500 u/ml (0-17 normal range). CT scan of the chest demonstrated multiple pulmonary nodules consistent with Caplan's syndrome. The prevalence of Caplan's syndrome in kaolin workers is the highest of any occupation ever reported.
2 Elevated cadmium levels of 11.2-15.9 mg/kg have been observed in kaolin, 3 fifty-fold higher than those reported in coal. 4 Coal contains variable amounts of clays and minerals such as kaolinite. Cadmium content in coal is strongly associated with levels of kaolinite contamination.
4 Cadmium
